542 related articles for article (PubMed ID: 16769901)
1. Minocycline inhibits poly(ADP-ribose) polymerase-1 at nanomolar concentrations.
Alano CC; Kauppinen TM; Valls AV; Swanson RA
Proc Natl Acad Sci U S A; 2006 Jun; 103(25):9685-90. PubMed ID: 16769901
[TBL] [Abstract][Full Text] [Related]
2. A novel and potent poly(ADP-ribose) polymerase-1 inhibitor, FR247304 (5-chloro-2-[3-(4-phenyl-3,6-dihydro-1(2H)-pyridinyl)propyl]-4(3H)-quinazolinone), attenuates neuronal damage in in vitro and in vivo models of cerebral ischemia.
Iwashita A; Tojo N; Matsuura S; Yamazaki S; Kamijo K; Ishida J; Yamamoto H; Hattori K; Matsuoka N; Mutoh S
J Pharmacol Exp Ther; 2004 Aug; 310(2):425-36. PubMed ID: 15075382
[TBL] [Abstract][Full Text] [Related]
3. Minocycline protects cardiac myocytes against simulated ischemia–reperfusion injury by inhibiting poly(ADP-ribose) polymerase-1.
Tao R; Kim SH; Honbo N; Karliner JS; Alano CC
J Cardiovasc Pharmacol; 2010 Dec; 56(6):659-68. PubMed ID: 20881608
[TBL] [Abstract][Full Text] [Related]
4. Poly(ADP-ribose) polymerase-1 promotes microglial activation, proliferation, and matrix metalloproteinase-9-mediated neuron death.
Kauppinen TM; Swanson RA
J Immunol; 2005 Feb; 174(4):2288-96. PubMed ID: 15699164
[TBL] [Abstract][Full Text] [Related]
5. Poly(ADP-ribose) glycohydrolase mediates oxidative and excitotoxic neuronal death.
Ying W; Sevigny MB; Chen Y; Swanson RA
Proc Natl Acad Sci U S A; 2001 Oct; 98(21):12227-32. PubMed ID: 11593040
[TBL] [Abstract][Full Text] [Related]
6. NAD+ as a metabolic link between DNA damage and cell death.
Ying W; Alano CC; Garnier P; Swanson RA
J Neurosci Res; 2005 Jan 1-15; 79(1-2):216-23. PubMed ID: 15562437
[TBL] [Abstract][Full Text] [Related]
7. On the way to selective PARP-2 inhibitors. Design, synthesis, and preliminary evaluation of a series of isoquinolinone derivatives.
Pellicciari R; Camaioni E; Costantino G; Formentini L; Sabbatini P; Venturoni F; Eren G; Bellocchi D; Chiarugi A; Moroni F
ChemMedChem; 2008 Jun; 3(6):914-23. PubMed ID: 18409175
[TBL] [Abstract][Full Text] [Related]
8. Astrocytic poly(ADP-ribose) polymerase-1 activation leads to bioenergetic depletion and inhibition of glutamate uptake capacity.
Tang KS; Suh SW; Alano CC; Shao Z; Hunt WT; Swanson RA; Anderson CM
Glia; 2010 Mar; 58(4):446-57. PubMed ID: 19795500
[TBL] [Abstract][Full Text] [Related]
9. Caffeine metabolites are inhibitors of the nuclear enzyme poly(ADP-ribose)polymerase-1 at physiological concentrations.
Geraets L; Moonen HJ; Wouters EF; Bast A; Hageman GJ
Biochem Pharmacol; 2006 Sep; 72(7):902-10. PubMed ID: 16870158
[TBL] [Abstract][Full Text] [Related]
10. Docosahexaenoic acid and tetracyclines as promising neuroprotective compounds with poly(ADP-ribose) polymerase inhibitory activities for oxidative/genotoxic stress treatment.
Cieslik M; Pyszko J; Strosznajder JB
Neurochem Int; 2013 Apr; 62(5):626-36. PubMed ID: 23439385
[TBL] [Abstract][Full Text] [Related]
11. Hypoglycemic neuronal death and cognitive impairment are prevented by poly(ADP-ribose) polymerase inhibitors administered after hypoglycemia.
Suh SW; Aoyama K; Chen Y; Garnier P; Matsumori Y; Gum E; Liu J; Swanson RA
J Neurosci; 2003 Nov; 23(33):10681-90. PubMed ID: 14627653
[TBL] [Abstract][Full Text] [Related]
12. Protective effect of nicotinamide against poly(ADP-ribose) polymerase-1-mediated astrocyte death depends on its transporter-mediated uptake.
Suzuki E; Okuda H; Nishida K; Fujimoto S; Nagasawa K
Life Sci; 2010 Apr; 86(17-18):676-82. PubMed ID: 20188745
[TBL] [Abstract][Full Text] [Related]
13. Involvement of independent mechanism upon poly(ADP-ribose) polymerase (PARP) activation in methylmercury cytotoxicity in rat cerebellar granule cell culture.
Sakaue M; Mori N; Okazaki M; Ishii M; Inagaki Y; Iino Y; Miyahara K; Yamamoto M; Kumagai T; Hara S; Yamamoto M; Arishima K
J Neurosci Res; 2008 Nov; 86(15):3427-34. PubMed ID: 18627028
[TBL] [Abstract][Full Text] [Related]
14. Delocalization of nucleolar poly(ADP-ribose) polymerase-1 to the nucleoplasm and its novel link to cellular sensitivity to DNA damage.
Rancourt A; Satoh MS
DNA Repair (Amst); 2009 Mar; 8(3):286-97. PubMed ID: 19144573
[TBL] [Abstract][Full Text] [Related]
15. Poly(ADP-ribose) polymerase-1-induced NAD(+) depletion promotes nuclear factor-κB transcriptional activity by preventing p65 de-acetylation.
Kauppinen TM; Gan L; Swanson RA
Biochim Biophys Acta; 2013 Aug; 1833(8):1985-91. PubMed ID: 23597856
[TBL] [Abstract][Full Text] [Related]
16. Flavone as PARP-1 inhibitor: its effect on lipopolysaccharide induced gene-expression.
Geraets L; Moonen HJ; Brauers K; Gottschalk RW; Wouters EF; Bast A; Hageman GJ
Eur J Pharmacol; 2007 Nov; 573(1-3):241-8. PubMed ID: 17643414
[TBL] [Abstract][Full Text] [Related]
17. Vincristine attenuates N-methyl-N'-nitro-N-nitrosoguanidine-induced poly-(ADP) ribose polymerase activity in cardiomyocytes.
Zhang J; Chatterjee K; Alano CC; Kalinowski MA; Honbo N; Karliner JS
J Cardiovasc Pharmacol; 2010 Mar; 55(3):219-26. PubMed ID: 20375713
[TBL] [Abstract][Full Text] [Related]
18. N-methyl-N'-nitro-N-nitrosoguanidine activates multiple cell death mechanisms in human fibroblasts.
Lee MW; Kim WJ; Beardsley DI; Brown KD
DNA Cell Biol; 2007 Sep; 26(9):683-94. PubMed ID: 17678437
[TBL] [Abstract][Full Text] [Related]
19. Minocycline reduces plaque size in diet induced atherosclerosis via p27(Kip1).
Shahzad K; Thati M; Wang H; Kashif M; Wolter J; Ranjan S; He T; Zhou Q; Blessing E; Bierhaus A; Nawroth PP; Isermann B
Atherosclerosis; 2011 Nov; 219(1):74-83. PubMed ID: 21719015
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of poly(ADP-ribose) polymerase modulates tumor-related gene expression, including hypoxia-inducible factor-1 activation, during skin carcinogenesis.
Martin-Oliva D; Aguilar-Quesada R; O'valle F; Muñoz-Gámez JA; Martínez-Romero R; García Del Moral R; Ruiz de Almodóvar JM; Villuendas R; Piris MA; Oliver FJ
Cancer Res; 2006 Jun; 66(11):5744-56. PubMed ID: 16740713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
